References
- Larocque A, Hoffman RS. Levamisole in cocaine: unexpected news from an old acquaintance. Clin Toxicol (Phila) 2012; 50:231–41.
- Gilbert JW, Re: Xu N, Zhou W, Shuy L, Zhou G, Zhang N. Clinical and MRI characteristics of Levamisole-induced leukoencephalopathy in 16 patients. (Letter) J Neuroimaging 2009; 13:326–31.
- Buchanan JA, Lavonas EJ. Agranulocytosis and other consequences due to use of illicit cocaine contaminated with levamisole. Curr Opin Hematol 2012; 19:27–31.
- Anbarasan D, Campion P, Howard J. Drug-induced leukoencephalopathy presenting as catatonia. Gen Hosp Psychiatry 2011; 33:85.e1–3.
- Bianco F, Iacovelli E, Tinelli E, Lepre C, Pauri F. Recurrent leukoencephalopathy in a cocaine abuser. Neurotoxicology 2011; 32:410–2.
- Wu VC, Huang JW, Lien HC, Hsieh ST, Liu HM, Yang CC, Lin YH, Hwang JJ, Wu KD. Levamisole-induced multifocal inflammatory leukoencephalopathy. Clinical characteristics, outcome, and impact of treatment in 31 patients. Medicine 2006; 85:203–13.
- Lynch KL, Dominy SS, Graf J, Kral AH. Detection of levamisole exposure in cocaine users by liquid chromatography-tandem mass spectrometry. J Anal Toxicol 2011; 35:176–8.